We are excited to announce the launch of its newly designed website, https://corp.arcalis.co.jp/en/
The website features a fresh look, user-friendly navigation, and informative content to help visitors understand our mRNA service and facilities.

We are committed to establishing facilities and infrastructure capable of providing end-to-end services, including mRNA template synthesis, manufacturing of vaccines and therapeutics, as well as LNP production.

We aim to contribute to global health, starting from Fukushima and extending worldwide.